# SB-659032 Platelet Aggregation Study

> **NCT01745458** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 26 (actual)

## Conditions studied

- Atherosclerosis

## Interventions

- **DRUG:** SB-659032
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01745458
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2005-12
- **Final completion:** 2005-12
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2012-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01745458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01745458, "SB-659032 Platelet Aggregation Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01745458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*